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ABSTRACT 
 
 Preliminary data gathered by our lab suggests a requirement for lactate in the developing 
inner ear of zebrafish embryos, implicating the action of the Warburg effect in otic development. 
A potential regulator of this Warburg effect is the transcription factor foxm1, which may also be 
mediating the Wnt and Fgf signals known to pattern the inner ear. Studies of the effects of foxm1 
were performed with the heat-shock transgene hs:foxm1, morpholino oligomers for foxm1 
knockdown, and a TALEN-induced foxm1 knockout line. 
 In transgenic hs:foxm1 embryos the only observed effect of heat shocks was an increase 
foxm1 mRNA abundance. Regardless of heat shock time point or BIO, IWR-1, or 2DG treatment 
status, heat shocks did not cause changes in morphology or gene expression. Several 
hypothetical explanations for the transgene’s ineffectiveness were tested, with new experiments 
planned to continue the exploration of the effects of foxm1 overexpression. Knockdown of foxm1 
by morpholino oligomers resulted in significant dorsalization, severely reduced Wnt signaling, 
altered Fgf target gene expression, and reduced pgk1 expression. These results support the 
hypothesized role of foxm1 as a Warburg regulator and a mediator of Wnt and Fgf signaling. A 
foxm1 knockout allele was generated with the use of TALENs, and a foxm1 knockout line was 
created. For unknown reasons, this knockout mutation was not observed to have any effect on 
morphology or gene expression. To test whether this was due to an early rescue effect, an 
attempt was made to generate maternal-zygotic mutants, but due to breeding issues the 
phenotype of MZ foxm1 mutants remains unknown. Further experiments, possibly including the 
creation of another foxm1 knockout allele, will be necessary to explore the true effects of foxm1 
knockout. It is our hypothesis that the foxm1 knockout phenotype, in the absence of any genetic 
compensation effects, will resemble the foxm1 morphant phenotype. 
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INTRODUCTION 
 
 
The inner ear is responsible for both auditory and vestibular perception, and disruptions 
of its development can lead to serious sensory disorders such as deafness or vertigo. Some of 
these cases can be attributed to mutations that are well-studied, but for many cases the genetic 
cause remains unknown (Grindle et al. 2014, Eppsteiner & Smith 2011). Prior studies and 
preliminary experiments conducted by our lab have indicated that the transcription factor foxm1 
represents a promising research target for elucidating the genetic and cell signaling mechanisms 
which control otic development.  
The process of selecting foxm1 as a transcription factor of interest began with the 
identification of the mutation sagd1, which was generated by our lab in zebrafish via ENU 
mutagenesis. This mutation produced a phenotype with several otic development deficiencies. 
The sagd1 mutants had reduced numbers of vestibular statoacoustic ganglion (SAG) neurons, 
half the normal number of hair cells, and reduced expression of several genes known to be 
targets of Fgf signaling, including ngn1, etv5b, and pax5 (Millimaki & Sweet et al. 2007, Roehl 
& Nüsslein-Volhard 2001, Kwak et al. 2006). After several days, expression of these genes 
began to return to wild-type levels, but all homozygotes died between days 7 and 10 despite the 
absence of major defects outside of the ear. Whole genome sequencing revealed that the 
mutation was in the gene pgk1 which encodes the glycolytic enzyme phosphoglycerate kinase 1. 
The identity of this mutation was confirmed by a CRISPR-generated pgk1 knockout that was 
found to have an identical phenotype. Loss of this gene explained the embryos’ eventual death, 
but it did not explain the specific developmental defects occurring in the inner ear. 
To determine how a glycolysis deficiency specifically affects otic development, 
glycolysis and subsequent metabolic steps were inhibited in wild type embryos via treatment 
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with either the glycolysis inhibitor 2DG, the LDHA inhibitor galloflavin, or the lactate 
membrane transport inhibitor UK-5099 (Wick et al. 1957, Farabegoli et al. 2012, Corbet et al. 
2018). All three treatments produced a phenotype identical to the pgk1-/- mutant, indicating that 
the ability to both produce and transport lactate is necessary for otic development. Additionally, 
treatment with exogenous lactate rescued pgk1-/- SAG neuron counts and Fgf target gene 
expression. Lactate treatment in wild type embryos led to increased SAG neuron counts and Fgf 
target gene expression compared to untreated embryos. These results indicate that lactate 
synthesis and secretion are required for normal otic development. Dependence on lactate is 
typical of a mode of metabolism historically associated with cancer cells, known as the Warburg 
Effect.  
The Warburg Effect (a.k.a. “aerobic glycolysis”) was originally discovered in cancer cells 
and refers to a shift in metabolism in which these cells, regardless of oxygen availability, will 
convert the bulk of their pyruvate into lactate rather than using it in the citric acid cycle 
(Warburg 1956). In more recent years, it has been discovered that the Warburg Effect may not be 
solely a trait of cancer as it is also being utilized during development. The Warburg Effect has 
been observed to occur in the developing retina of frogs, in the posterior presomitic mesoderm of 
mice and zebrafish, and in human neural, hematopoietic, and pluripotent stem cells 
(Agathocleous et al. 2012, Bulusu et al. 2017, Gu et al. 2016, Oginuma et al. 2017, Sá et al. 
2017, Wang et al. 2014, Zheng et al. 2016). These studies demonstrate the requirement for 
lactate in developing tissues, though there are multiple hypotheses as to why this is the case. One 
is that the rapid glycolysis generates sufficient ATP and the lactate that is subsequently produced 
serves as a pool of short carbon chains that the cell can then use for biosynthesis. Having this 
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resource available is important for a cell that is undergoing frequent division, but it is possible 
that lactate may have a cell signaling function as well (Liberti & Locasale, 2016).  
It has been demonstrated that lactate can have a signaling role within the cell by binding 
and stabilizing the protein Ndrg3, thus preventing it from being degraded and allowing it to 
activate Raf-MAPK signaling (Lee et al. 2015). This is notable as it is the same pathway used to 
transmit Fgf signals, which are known to be required for the induction and maintenance of otic 
development (Ornitz & Itoh 2015, Phillips et al. 2004, Freter et al. 2008). As MAPK activity is 
induced by both Fgf signals and lactate, transcription of Fgf target genes is increased, including 
ETS factors such as etv4 and etv5b, among others (Raible & Brand 2001, Roehl & Nüsslein-
Volhard 2001). These genes are significant because their protein products are then 
phosphorylated and activated by MAPK and will act as transcription factors to mediate many of 
the downstream effects of Fgf. Thus, increased available lactate augments Fgf signaling by 
increasing the rate of transcription of ETS factors and allowing for their protein products to 
facilitate more rapid activation of downstream Fgf target genes. This would mean that for the 
pgk1-/- mutants generated in our lab, the otic development defects that were observed were 
likely due to insufficient Fgf activity caused by disrupted glycolysis and lack of functioning 
Warburg metabolism. All of this evidence supports a role for Warburg metabolism in otic 
development, but it is unclear how this process is regulated. A candidate gene for Warburg 
regulation in otic development is the transcription factor foxm1, the focus of this research project.  
The gene foxm1 belongs to the FOX (forkhead box) family of transcription factors. 
Members of the FOX family possess a forkhead DNA binding domain, a unique feature first 
discovered in the family’s founding gene fkh in Drosophila melanogaster (Weigel et al. 1989). 
Since the discovery of fkh, numerous FOX genes have been identified in many different animals. 
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In humans, 50 FOX genes have been identified and categorized into 19 subgroups, designated 
FOXA through FOXS. FOX genes are assigned to these different subgroups based on their 
sequence similarity and the organization of their functional domains (Lam et al. 2013). FOXM1 
is the sole member of the FOXM subgroup, and is highly conserved between humans and 
zebrafish.  
FOXM1 has been mostly studied in the context of cancer biology, as it has a powerful 
effect on promoting cell division and has been observed to be upregulated in many metastatic 
tumors (Milewski et al. 2017, Chen et al. 2013). Among such studies, it has been observed that 
Foxm1 promotes Warburg metabolism by upregulating expression of both Pgk1 and LDHA in 
order to create abundant lactate. It has also been shown that Foxm1 is directly activated by 
MAP2K (a.k.a. MEK) (Ma et al 2005). Another detail which makes foxm1 an attractive 
candidate for study is that there is evidence that it may mediate the effects of Wnt signaling. Wnt 
signals control cell fate decisions during otic development and maintain the integrity of the otic 
placode, a precursor structure to the inner ear (Phillips et al. 2004, Ohyama et al. 2006). Wnt 
signaling relies on the activity of β-catenin, a constitutively expressed protein in the cytoplasm 
that is normally quickly degraded by the APC complex. However, upon Wnt activation, this 
degradation is inhibited and β-catenin is translocated to the nucleus (MacDonald et al 2009, 
Kimelman & Xu 2006). The manner in which this nuclear translocation occurs has been a matter 
of ongoing investigation, as there may be more than one mechanism. One way in which this has 
been shown to occur is that cytoplasmic β-catenin binds to Foxm1 and then moves into the 
nucleus where these proteins can then bind to the transcription factors TCF and LEF. This 
protein complex then promotes transcription of Wnt target genes (Zhang et al. 2011).  
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The goal of this project is to investigate the role of the transcription factor foxm1 during 
otic development. I hypothesize that Foxm1 mediates Fgf and Wnt signaling activity to levels 
sufficient for proper inner ear patterning and development. I further hypothesize that this system 
relies on Foxm1 modulating the activity of the Warburg effect, a mode of metabolism in which 
glycolysis and lactate production are highly elevated, despite the presence of oxygen. In this 
study, these hypotheses have been investigated through the use of zebrafish embryos containing 
heat shock inducible transgenes and knockout mutations, as well as with pharmacological 
activators and inhibitors and morpholino oligomers.  
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MATERIALS AND METHODS 
 
 
Fish Strains and Developmental Conditions 
All adult fish were maintained in a facility inspected and approved by the Institutional 
Animal Care and Use Committee (IACUC). Wild-type embryos were from the AB and TL lines. 
Transgenic lines used in this study included Tg(hsp70:fgf8a)x17 and Tg(hsp70:foxm1). Transgenic 
lines are named in the text as hs:fgf8 and hs:foxm1, respectively. Two foxm1 mutant lines were 
created via TALEN-mediated gene targeting and were used for loss of function analysis. Mutants 
were identified using the screening methods described below. Embryos were maintained at 
28.5°C (except where noted) and staged according to standard protocols (Kimmel et al. 1995). 
PTU (1-phenyl-2-thiourea, 0.3 mg/mL; Sigma) was added to block pigment formation where 
necessary.  
 
Heterozygous and Homozygous foxm1 Mutant Screening 
Heterozygous and homozygous mutants were identified primarily through single embryo 
PCR genotyping. The fish being screened were each outcrossed with a wild type fish and eight 
embryos were collected. DNA was extracted from each embryo and the region of the foxm1 
sequence surrounding the TALEN-targeted region was amplified using PCR. This PCR product 
was then digested with a restriction enzyme and the restriction digest products were separated by 
gel electrophoresis. The TALEN edit disrupts a restriction enzyme cut site, and so the gel 
electrophoresis result allows for genotyping of the embryos. The genotypic ratio of the embryos 
allows for genotyping of the screened parent; a heterozygous parent outcrossed to wild type will 
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produce offspring that are 50% heterozygous and 50% wild type, while a homozygous parent 
outcrossed to wild type will produce offspring that are 100% heterozygous.  
Some heterozygotes and homozygotes were alternatively identified by fin-clip 
genotyping. Adult fish were anesthetized in a tricaine solution and a small clipping of the anal 
fin was collecting using alcohol-sterilized microscissors, with the fish then being moved to 
individual recovery tanks. DNA was obtained from the fin clip tissue via proteinase K digestion. 
Screening was then carried out in the same way as the protocol described above, utilizing PCR, 
HpaII digestion, and gel electrophoresis to identify heterozygotes and homozygotes.   
 
Heat Shock  
Embryos were collected, transferred to 50 mm petri dishes, and incubated at 28°C. At the 
specified heat shock time point, the petri dishes were floated in a hot water bath at 37°C or 39°C 
for 30 to 60 minutes. The heat shock time point, water temperature, and duration varied between 
experiments. Following heat shock, the petri dishes were transferred to a 33°C incubator and 
allowed to recover for one hour before being transferred back to the 28.5°C incubator until ready 
for examination and/or subsequent experiments.  
 
In Situ Hybridization 
Whole-mount in situ hybridization and antibody labeling were performed as previously 
described (Phillips et al. 2001, Riley et al. 1999), with probes for foxm1, pax5, pax2a, ngn1, top-
gfp, sp5a, sp5l, gsc, pgk1, and etv5.  
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Drug Treatment 
The drugs used in this study were BIO, IWR-1, and 2DG (all from Sigma). Liquid stocks 
were created by dissolving each in DMSO. Treatments were performed by diluting the stock to 
the appropriate concentration in standard embryo incubation water (“fish water”: distilled water 
with added salts and methylene blue). BIO and IWR-1 were diluted to a 10 mM concentration, 
and 2DG was diluted to a 250 µM concentration. At the appropriate time point, embryos were 
transferred to 50 mm petri dishes containing the drug solution. In experiments in which both heat 
shocks and drug treatments were applied, the embryos were transferred to the drug solution 
immediately after heat shock.   
 
RT-PCR 
Zebrafish mRNA was collected from embryos via a TRIzol and chloroform extraction. 
cDNA was synthesized through use of the SuperScript First-Strand Synthesis System RT-PCR 
kit from Invitrogen. PCR primers were designed based on foxm1 sequence data available on 
ZFIN.   
 
Morpholino Injection 
All morpholino oligomers were obtained from Gene Tools, LLC. MOs were diluted in 
Danieux buffer (Nasevicius & Ekker, 2000) to a concentration of 5 µg/μL prior to injection. All 
embryos were injected at the one-cell stage with the use of a Narishige IM-300 microinjector. 
Following injection, all embryos were incubated under the same conditions as other embryos, as 
described above.  
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TALEN Design, Synthesis, and Screening 
TALENs were designed with the assistance of the TAL Effector Nucleotide Targeter 2.0 
online tool from Cornell University. TALENs were assembled through use of a modified version 
of the Golden Gate TALEN Assembly protocol originally described in Cermak et al. 2011. 
TALENs were injected into one-cell stage embryos with the use of a Narishige IM-300 
microinjector. At 24 hours, DNA was extracted from a portion of the injected embryos. PCR was 
used to amplify the TALEN-targeted region, and the PCR product was subjected to a restriction 
enzyme digest (similar to methods described above) or a T7 digest to confirm the cutting ability 
of the TALEN. If the TALEN was identified to be an effective cutter, the remaining injected fish 
were raised to maturity for the origination of a new mutant line.  
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RESULTS 
 
 
Use of a Heat-shock Inducible Transgene to Overexpress Foxm1 
 
 
The hs:foxm1 transgene consists of an hsp70 heat-shock inducible promoter and the full 
cDNA of foxm1. This transgene was inserted into embryos using a meganuclease genome editing 
approach (Thermes et al. 2003). In situ hybridization (ISH) was used to identify hs:foxm1 
carriers, which were shown to have dramatically increased levels of foxm1 mRNA after heat 
shock compared to wild type zebrafish (data not shown). Unexpectedly, despite the presence of 
this transgene and the significant increase in foxm1 mRNA following a heat shock, little to no 
change was observed in either gene expression or embryonic morphology.  
 Embryos carrying hs:foxm1 were heat shocked for one hour in a 39°C water bath at 
various time points after fertilization to determine if Foxm1 overexpression would alter the 
morphology of the embryos, and more specifically if it would alter the morphology of the otic 
vesicle, the precursor structure of the inner ear. Applying these heat shocks at 6, 9, 10, 12, and 18 
hpf did not visibly alter the morphology of the embryos. In embryos heat shocked at 12 hpf and 
fixed at 24 hpf, ISH was used to evaluate the expression of genes known to be affected by Fgf or 
Wnt signals, including pax2a, pax5, ngn1, gsc, sp5a, sp5l, etv5b, and top-gfp (Ohyama et al. 
2006, Kwak et al. 2006, Millimaki & Sweet et al. 2007, Kantarci et al. 2016, Weidinger et al. 
2005, Roehl & Nüsslein-Volhard 2001, Horst et al. 2012). No significant differences in 
expression for any of these genes were observed when comparing heat-shocked hs:foxm1 
embryos to control embryos (Figure 1). 
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The lack of perceptible effects in the initial heat shock experiments was unexpected, and 
indicated that some other factor may have been inhibiting the effects of overexpressed Foxm1. 
Two of the primary ways in which FoxM1 is regulated are by phosphorylation via MAPK, and 
degradation via the APC complex (Ma et al. 2005, Park et al. 2008). We hypothesized that it was 
possible that although Foxm1 expression had been significantly increased via the heat shock 
transgene, the effects of the Foxm1 protein were possibly being mitigated by one of these two 
regulatory mechanisms. It was possible that while Foxm1 levels were high, there was not a 
sufficient level of MAPK to activate the now-abundant Foxm1. It was also possible that the APC 
complex was able to degrade the excess Foxm1 protein before it could have an effect on 
development. To test these hypotheses, a series of experiments was performed utilizing the drugs 
BIO, IWR-1, and 2DG, as well as the heat shock transgene hs:fgf8. Contrary to our predictions, 
the results of these experiments also indicated that hs:foxm1 did not have any effect on gene 
expression or morphology (Figure 2). 
In the first of these experiments, the drugs BIO and IWR-1 were used. BIO prevents the 
APC complex from forming via inhibition of GSK3, and IWR-1 stabilizes the APC complex by  
Figure 1. Effects of hs:foxm1 on gene expression in the otic vesicle of zebrafish embryos at 
24 hpf. All views are dorsolateral except gsc which is dorsal. All images taken at 200x 
magnification except ngn1 which was taken at 100x.  
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binding to Axin. Control embryos were treated with either BIO or IWR-1 or a heat shock 
individually, while experimental embryos received either BIO or IWR-1 in addition to a heat 
shock. In all cases, BIO and IWR-1 were applied as 10 mM doses at 13 hpf immediately 
following heat shocks performed at 12 hpf. Gene expression did not appear to be significantly 
affected by overexpressed Foxm1 in these experiments, as hs:foxm1 embryos receiving both a 
heat shock and drug treatment had the same levels of gene expression as the drug-only controls 
(Figure 2). These results indicate that activity of the APC complex is not the reason why 
hs:foxm1 has no apparent effects.  
Another experiment to assess the impact of the hs:foxm1 transgene was performed in 
which hs:foxm1 heterozygotes were bred with hs:fgf8 homozygotes. It was hypothesized that if 
insufficient levels of MAPK activity were responsible for the lack of an effect by hs:foxm1, an 
Figure 2. Effects of combining BIO or IWR-1 treatment with hs:foxm1 on gene expression 
in the otic vesicle of zebrafish embryos. All views are dorsolateral, all images taken under 200x 
magnification. 
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increase in MAPK activity caused by Fgf8 overexpression would allow overexpressed Foxm1 to 
become activated and have a significant effect on embryo morphology. At 6 hpf, some of the 
embryos received a mild heat shock, some received a dose of BIO, and some received both 
treatments. Due to the genotypes of the parents, all of the embryos would possess hs:fgf8 while 
only half would also possess hs:foxm1. It was expected that combining BIO treatment with 
hs:fgf8 activity would cause both APC complex inhibition and increased MAPK activation, 
allowing Foxm1 to have the strongest possible effect. Despite the combination of all of these 
factors, no difference was seen between the embryos containing both transgenes and the ones 
containing only hs:fgf8. In early trials it was observed that there was some variation in phenotype 
with the morphological effects on some embryos appearing milder and some more severe, but 
genotyping the embryos via PCR revealed that these differences were not correlated with 
hs:foxm1 status. Under these extreme conditions, hs:foxm1 still did not appear to have any 
discernible impact (Figure 3). 
A final drug treatment experiment was performed with the glycolysis inhibitor 2DG to 
test the ability of the hs:foxm1 transgene to influence Warburg metabolism. It was hypothesized 
that 2DG-treated embryos would perform glycolysis at a slower rate and generate less lactate for 
Warburg metabolism, but that overexpression of Foxm1 could allow compensation to occur by 
increasing the expression of Pgk1 and LDHA, thereby increasing the impact of each round of  
glycolysis able to be completed in the presence of 2DG. Embryos received a dose of 2DG at 14 
hpf and a heat shock at 16 hpf. Embryos were fixed and imaged at 18 or 20 hpf to observe the 
effects of the treatments at differing time points. The genes pax5 and etv5b were used as markers 
for changes in Warburg metabolism because both are known to be affected by Fgf signals (Kwak 
 
 
 
14 
 
 
 
et al. 2006, Roehl & Nüsslein-Volhard 2001). In the case of both pax5 and etv5b, 2DG appeared 
to have fairly mild effects, with expression of both genes in control embryos returning to normal  
by 20 hpf. In both 2DG-treated embryos and heat shock control embryos, heat shock treatment 
did not appear to significantly affect the total level of gene expression for either pax5 or etv5b, 
but it did appear to alter the pattern of etv5b expression; the etv5b staining pattern in heat-
shocked embryos appeared more diffuse than in control embryos, with the three bands between 
the otic vesicles becoming less well-defined (data not shown).This data indicates that hs:foxm1 
does not rescue embryos from the effects of 2DG. 
All of these data illustrated an apparent absence of effect from hs:foxm1 and prompted an 
investigation of the transgene. Sequencing data revealed that the transgene sequence was 
identical to the native zebrafish foxm1 cDNA, which shares a high degree of sequence identity 
with the FOXM1c splice isoform found in mammals. 
Figure 3. Effects of heat shock and BIO treatments on hs:foxm1(het);hs:fgf8(homo) 
zebrafish embryos. (A) HS only, a very mildly affected embryo, similar phenotype to wild type. 
(B) HS only, a severely affected embryo, showing a phenotype characteristic of hs:fgf8 activity. 
(C) HS and BIO, a severely affected embryo, similar to B. (D) HS and BIO, several dead and 
dying embryos as a result of combined BIO and hs:fgf8 activity. 
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Mammals possess three splice isoforms produced from FOXM1, which are FOXM1a, 
FOXM1b, and FOXM1c. They differ from each other by their possession of two additional 
exons, A1 and A2 (Figure 4) (Wierstra & Alves 2007, Kong et al. 2013).  These exons encode 
autoinhibitory protein domains which reduce FOXM1’s ability to act as a transcription factor. 
FOXM1a contains both A1 and A2, and has been found to be fully transcriptionally inactive. 
FOXM1b contains neither A1 nor A2, and has the greatest amount of transcriptional activity. 
FOXM1c contains only A1, and is transcriptionally active but has a much weaker effect than 
FOXM1b due to the autoinhibitory effects of its A1 domain. In zebrafish, the only reported 
Foxm1 cDNA sequence most closely matches the mammalian FOXM1c isoform. It was then 
hypothesized that the autoinhibitory nature of the A1 domain of FOXM1c may be why 
overexpressing zebrafish Foxm1 had a minimal effect, and that if a Foxm1 isoform equivalent to 
FOXM1b exists in zebrafish, this could be used to create a much stronger transgene. 
An RT-PCR approach was used to attempt to identify the splice isoforms of Foxm1 in 
zebrafish. PCR primers were designed to target areas near the beginning and end of the foxm1 
cDNA (Figure 4), and thus would produce three different products if all three isoforms were  
 
Figure 4. The three splice isoforms of FOXM1 known to exist in mammals and 
hypothesized to exist in zebrafish. Marked on each isoform’s diagram in red is the target site of 
the PCR primers developed to amplify the different isoforms from zebrafish cDNA. A1 and A2: 
The A1 and A2 autorepression domains, NRD: N-terminal repressor domain, FKH: Forkhead 
DNA-binding domain, TAD: transactivation domain. 
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present. Gel electrophoresis following PCR revealed only one product, and this was of the 
expected size for the FOXM1c isoform. This result combined with the lack of any other 
zebrafish Foxm1 splice isoform reports in zebrafish genetic databases suggests that the 
FOXM1c-like isoform is likely the only one present in zebrafish. 
One final future direction exists for the hs:foxm1 transgene, which is to remake the 
transgene with a different genetic editing system. Our current transgene was created by using a 
meganuclease system, an older and less reliable method than the more efficient Tol2 system. 
Previous meganuclease-generated heat shock transgenes in our lab have been observed to be 
similar to hs:foxm1 in that a heat shock dramatically increases transcript abundance, but causes 
little to no effect on gene expression. It is not clear why this occurs, but it is possible that 
remaking hs:foxm1 with the Tol2 system would produce a more functional transgene with which 
all of the hs:foxm1 experiments could be repeated.  
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Knockdown of Zebrafish Foxm1 by Morpholino Oligomers 
 
 
Morpholino oligomers (MOs) are synthetic oligonucleotides that have a 
methylenemorpholine backbone linked by phosphorodiamidate groups rather than a ribose 
backbone linked by phosphate groups. They contain a sequence of RNA bases which allows 
them to bind to a matching pre-mRNA or mRNA molecule, and their synthetic backbone 
prevents splicing or translation, respectively. This backbone also makes them difficult for 
cellular machinery to remove, and so they are able to effectively inhibit expression of a target 
gene for an extended period of time (Bill et al 2009). A Foxm1 translation blocker MO was 
developed by our lab to knock down Foxm1 expression and study the effects on zebrafish 
embryos (Figure 5, Morpholino B), and two additional MOs were later created to verify the 
results of experiments performed with the initial MO (Figure 5, Morpholinos A and C). 
 
 
 
 
 
Figure 5. Morpholino oligomer target sites on foxm1 mRNA. Morpholino B is the original 
morpholino used for all of the preliminary experiments. Morpholinos A and C were later used to 
validate the results of Morpholino B. In the foxm1 mRNA diagram, coding exons are shown in 
blue, foxm1’s initial noncoding exon is shown in white, and exon 6 is shown in light blue to 
denote its status as encoding the A1 autorepression domain. 
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Zebrafish embryos were injected with Foxm1 MO at the one-cell stage and were 
evaluated for morphological changes at 24 hpf. Many of the morphants did not survive to 24 hpf, 
and those that did were severely dorsalized, possessing a head, an extremely shortened trunk, and 
a shrunken and curled tail (Figure 6). This phenotype is identical to that of zebrafish wnt8 
mutants, indicating that the likely reason for this extreme morphological effect is a disruption in  
Wnt signaling caused by an inability of β-catenin to translocate to the nucleus in the absence of 
Foxm1 (Lekven et al. 2001). ISH was used to examine levels of expression of pax2a, pax5, 
ngn1, gsc, and pgk1 in Foxm1 morphants at 24 hpf. Expression of pax2a, pax5, ngn1, and gsc 
were all expressed similarly to wild type embryos aside from disruptions of their total area of 
expression caused by the severe morphological disruptions of the morphant. However, pgk1 
expression at 24 hpf appeared to be significantly lower than in wild type embryos, and appeared 
nearly absent in several of the morphants (Figure 6).  
 
 
 
 
Figure 6. pgk1 expression is dramatically reduced in foxm1 morphants. Expression of pgk1 
was reduced or completely depleted specifically in the hindbrain region of zebrafish embryos. 
Morphants display similar morphological issues to wnt8 mutants (right). ISH images taken at 24 
hpf at 100x magnification. Whole-embryos image taken at 40x magnification. mhb =  midbrain-
hindbrain border, hb = hindbrain. 
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This supports prior studies which have shown Foxm1 to regulate Pgk1 expression and further 
supports Foxm1 knockdown as being the cause of the extreme morphological changes observed 
in the morphant embryos, rather than unintended off-target effects from the morpholino.   
When examined at the earlier stage of 10.5 hpf, the effects of the Foxm1 MO were even 
more striking. Morphant embryos appeared to become ovular and elongated, which is indicative 
of dorsalization. ISH revealed that expression of top-gfp, a marker of Wnt signaling, is nearly 
completely absent in morphants, indicating that Foxm1 knockdown is very strongly inhibiting 
Wnt signals (Figure 7). The expression domain of etv5b, and indicator of Fgf signaling and 
dorsal and posterior identity, is dramatically expanded throughout the embryo, with the hindbrain 
expression of etv5b expanding fully into the ventral region, indicating that nearly the entire 
embryo has obtained a dorsal identity (Figure 7). This extreme early dorsalization is likely why 
so many of the morphant embryos do not survive to 24 hpf. 
 One potential issue when using morpholinos is that they will sometimes bind non-
specifically to a different mRNA than that of the intended target, thus causing a misleading 
phenotype. For this reason, we created two additional morpholinos to validate the morpholino 
results we had obtained thus far (Figure 5). Both of these morpholinos targeted different regions 
of the foxm1 mRNA, yet the resulting phenotypes from each of them were essentially identical to 
the original morphant phenotype, although there was a slightly more pronounced continuum of 
severity with less lethality observed. These results indicate that the phenotype is a specific effect 
of Foxm1 knockdown and not the result of any off-target effects. 
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Figure 7. top-gfp and etv5b expression in foxm1 morphants at 10.5 hpf. The elongated, ovular 
shape of morphants indicates dorsalization. In most morphants, top-gfp expression is entirely 
absent, and etv5b expression reveals the level of dorsalization to be so severe that hindbrain 
identity extends into the ventral region of the embryo. A = anterior, D = dorsal, P = posterior, V 
= ventral, hb = hindbrain. 
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Knocking Out foxm1 
 
 
A TALEN was designed to knock out foxm1 and eventually create a zebrafish foxm1 -/- 
mutant line. TALEN-injected founders were screened via an HpaII restriction enzyme digest 
assay and foxm1 +/- embryos were obtained. DNA sequencing revealed that the knockout allele 
contained a 5 bp deletion in the first coding exon of foxm1, predicted to cause a desired 
premature stop following 175 nucleotides of nonsense. When the foxm1 +/- fish reached 
maturity, they were bred to obtain foxm1 -/- embryos. It was predicted that the homozygous 
mutants would resemble the Foxm1 morphants, but these embryos appeared fully wild type both 
morphologically and in the expression of several genes including pax2a, pax5, ngn1, and gsc 
(data not shown). Through development and into maturity, these fish lacked visible defects and 
were not discernible from other fish except through use of the HpaII screening assay.  
One potential reason for the lack of an observable foxm1 -/- phenotype is a maternal 
effect caused by the presence of maternal foxm1 mRNA in the egg originating from the foxm1 
+/- parent. 
 
Figure 8. Maternal foxm1 mRNA in 16-cell stage zebrafish embryos. Left: animal pole view, 
40x. Right: lateral view, 40x 
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 ISH revealed that at the 16-cell stage (prior to activation of the zygotic genome, which occurs at 
the 1,000-cell stage in zebrafish), zebrafish embryos contain very high levels of foxm1 mRNA 
(Figure 8). 
 In order to eliminate this maternal mRNA as a factor that may limit the effect of the 
foxm1 mutation, the progeny of a foxm1 +/- intercross were raised to maturity and several foxm1 
-/- fish were identified. Breeding these fish should create maternal-zygotic mutants lacking any 
foxm1 maternal effects. Several rounds of breeding produced many eggs, all of which failed to 
develop. These results are inconclusive, as it is not clear if this was due to a lack of foxm1 or 
another factor. Unfortunately, the foxm1 -/- parents in these crosses were lost, and more foxm1 -/- 
fish will need to be obtained to pursue a true foxm1 maternal-zygotic mutant.   
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DISCUSSION AND CONCLUSIONS 
 
 
The goal of this project was to investigate the role of the transcription factor foxm1 in otic 
development, including its effects on mediating Fgf and Wnt signaling during otic development 
as well as its function as a regulator of the Warburg effect. This study began with the use of the 
hs:foxm1 transgene with the aim of observing the effects of foxm1 overexpression on otic 
development, embryo morphology, and expression of Fgf and Wnt target genes. Given that 
foxm1 is known to be a powerful promoter of cell division (Chen et al. 2013), it was expected 
that heat shocks of these transgenic embryos would cause profound alterations not just in otic 
development but also possibly in overall embryo morphology. Surprisingly, despite foxm1 
mRNA expression being observed to significantly increase, heat shock treatments of hs:foxm1 
fish did not appear to alter development in any way, regardless of heat shock time point or 
duration. This remained true even when other heat shock transgenes were present, such as 
hs:fgf8, or the drugs BIO, IWR-1, and 2DG were applied; the effects of hs:fgf8 and the drug 
treatments were evident, but the added presence of hs:foxm1 did not appear to have any effect. 
After collecting these data, the presence of hs:foxm1 in the transgenic line was checked and 
confirmed by PCR and sequencing which verified that it was indeed present.  
Together, the data obtained throughout experiments with the hs:foxm1 line suggest that 
something must be preventing the heat-shock overexpression of this particular transgene from 
having an effect on development. One possibility was that the zebrafish foxm1 cDNA used to 
create the transgene was of a splice isoform which contained one or more exons encoding 
autoinhibitory domains which would cause the Foxm1 protein to inhibit its own function. 
Sequencing of the hs:foxm1 transgene revealed that it was identical in sequence to the only 
 
 
24 
 
previously reported zebrafish foxm1 cDNA sequence. This cDNA sequence has a high degree of 
identity with the human FOXM1c splice isoform, which does indeed encode an autoinhibitory 
domain in its A1 exon. The human FOXM1b splice isoform contains no such autoinhibitory 
domains and so an equivalent isoform in zebrafish would potentially allow for creation of a far 
stronger heat shock-inducible transgene. An RT-PCR experiment was conducted to find and 
identify other splice isoforms of Foxm1 in zebrafish, but unfortunately none besides the 
FOXM1c-like isoform were found.  
Based on these comparisons to human data, it may be possible that the lack of effect from 
hs:foxm1 can be explained by the presence of an autoinhibitory domain. However, while the 
zebrafish foxm1 and human FOXM1c sequences have a high degree of identity, they are not 
totally identical, and they have a number of differences in sequence content and length in the 
region of this A1 exon/autoinhibitory domain. It is possible then that perhaps zebrafish foxm1 
does not actually exert an autoinhibitory effect or that the effect is not strong enough to suppress 
the effects of heat-shock overexpression. It may be the case that the failure of hs:foxm1 to elicit 
developmental changes may be for another reason, such as the nature of the meganuclease 
system by which this transgene was created. It is unclear how this would be occurring, but other 
transgenes created by our lab with this system in the past have demonstrated similar issues to 
those of hs:foxm1, with mRNA overexpression being visible while all other expected effects are 
weak or absent. When new versions of these transgenes were later made using the newer and 
more efficient Tol2 system, their effects were immediately visible and the issues were resolved. 
In continuing the investigation of the effects of foxm1 overexpression, remaking the transgene 
with the Tol2 system or another newer genetic editing tool will likely be necessary.  
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In addition to attempts to overexpress foxm1, knockdown experiments were performed 
through use of morpholino oligomers. The results of these experiments support many of the 
hypotheses made about the role of foxm1. The dorsalized morphology of the morphants 
(resembling wnt8 mutants) and the changes in top-gfp and etv5b expression demonstrate that 
foxm1 is a mediator of Wnt and Fgf signaling. The reduction in pgk1 expression in the area 
closest to the otic vesicle but not in the somites indicates not only that foxm1 is regulating the 
Warburg effect, but that this is occurring in a specific manner and in a specific area, which is 
supportive of our hypotheses about the role of foxm1 in relation to otic development. To verify 
that these observations were due specifically to knockdown of foxm1 and not unintended off-
target effects, two additional MOs were tested and found to have nearly identical effects to the 
first MO. These results provide strong support for the observed morphant phenotype being a 
specific consequence of foxm1 knockdown.  
Although matching results were obtained with three different MOs, further verification of 
the observed phenotype by use of a mutant line was necessary due to the troubling number of 
instances in which morphant and mutant phenotypes do not resemble one another (Kok et al. 
2015). A TALEN was created to induce a knockout mutation in foxm1, and the presence of this 
mutation in embryos was confirmed by both a restriction enzyme assay and sequencing. Despite 
the fact that this mutation (a 5 bp deletion) caused a frame shift and should have led to a fairly 
early premature stop in translation, embryos homozygous for the mutation did not appear to have 
any developmental defects whatsoever. This was unexpected, and it was hypothesized that this 
may be due to a possible rescue effect from the high amount of foxm1 maternal mRNA that was 
observed to be present in early stage embryos. Crosses of foxm1 -/- fish were performed in an 
effort to obtain maternal-zygotic mutants, but all of the embryos from these crosses failed to 
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develop. This failure of development may have been due to the lack of maternal foxm1 or some 
other unknown factor, but the parent fish were lost before this could be investigated further.  
In order to continue this study of foxm1 and its role in otic development, several projects 
mentioned previously must be pursued. The first of these is that a new heat shock transgene must 
be made with a newer, more efficient genetic editing tool. This new transgene will reveal 
whether the issues with hs:foxm1 encountered in this study were due to the effects of the 
autoinhibitory domain of the Foxm1 protein or due to unknown issues with the insertion of the 
transgene. More importantly, this new transgene will allow for the true effects of foxm1 
overexpression to be investigated.  
 In regard to the foxm1 mutant line, the first task will be to obtain more foxm1 -/- fish with 
which to produce more maternal-zygotic mutants. If the developmental issues of these mutants 
are observed throughout these new crosses, a different approach may be needed to observe the 
effects of foxm1 knockout. One such approach would be the creation of a floxed allele for foxm1. 
A floxed allele, by allowing for temporally-controlled knockout of foxm1, would allow embryos 
to survive past the earliest and most critical stages of development before losing the gene.  
 Despite sequencing data for the TALEN-generated foxm1 mutation indicating a frame 
shift and premature stop, the mutation is not causing the developmental defects that would be 
expected. It is unclear why this is occurring, but one possibility is that there is another 
transcription factor present which may be compensating for the loss of foxm1, activated either by 
signaling changes that emerge as a consequence of a loss of foxm1 or by the effects of nonsense-
mediated decay of the mutant foxm1 mRNA. It is also possible that this lack of an effect from the 
foxm1 mutation is due to some other unknown reason, and the creation of a new knockout 
mutation for comparison may aid in clarifying the puzzling nature of the current knockout. 
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